Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,018 public trials 2,029 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Clinical Trial of HuMax-CD4, a New Drug to Treat Advanced Stage T-Cell Lymphoma in the Skin.

NCT00071084

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Stanford University Med Ctr., Dept of Dermatology Stanford, California, United States
  • University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States
  • Münster, Germany
  • Stockholm, Sweden
View Trial Details
Completed

Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma

NCT01092182

Conditions
Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +29 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States
  • Emory University /Winship Cancer Institute Atlanta, Georgia, United States
  • University of Illinois Chicago, Illinois, United States
View all 30 locations
View Trial Details
Completed

A Clinical Study of SHP674 (Pegaspargase) in Participants With Newly Diagnosed, Untreated Acute Lymphoblastic Leukemia

NCT04067518

Conditions
Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Kagoshima University Hospital Department of Pediatrics Kagoshima, Japan
  • Kobe Children's Hospital Department of Hematology/Oncology Kobe, Japan
  • Nagoya Medical Center Department of Pediatrics Nagoya, Japan
  • Niigata Cancer Center Hospital Niigata, Japan
View Trial Details

Related conditions